A Surprisingly Clean, Straightforward Approval Gives Portola Pharma Shares A Shot Of Upside
June 26, 2017 at 14:03 PM EDT
Portola Pharmaceuticals Inc (NASDAQ: PTLA) announced last Friday the FDA has approved Brvyxxa, its anti-coagulant candidate. ...